Chison Medical Technologies Co., Ltd. (SHA:688358)
26.33
-0.33 (-1.24%)
Nov 13, 2026, 3:00 PM CST
SHA:688358 Revenue
Chison Medical Technologies had revenue of 109.58M CNY in the quarter ending September 30, 2026, with 2.40% growth. This brings the company's total for the last twelve months to 443.67M, down -1.32% year-over-year. In the year 2025, Chison Medical Technologies had annual revenue of 435.81M, down -7.02%. That makes Chison Medical Technologies the 25,847th largest company in the world by revenue and 4,569th in China.
Revenue (ttm)
443.67M
Revenue Growth
-1.32%
P/S Ratio
6.65
Revenue / Employee
928.18K
Employees
478
Market Cap
2.95B
Revenue by Geography
- Overseas 396.43M 91.0%
- China 39.17M 9.0%
Fiscal year ended Dec 31, 2025 See the full SHA:688358 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 435.81M | -32.89M | -7.02% |
| Dec 31, 2024 | 468.70M | -15.14M | -3.13% |
| Dec 31, 2023 | 483.84M | 103.00M | 27.04% |
| Dec 31, 2022 | 380.84M | -16.97M | -4.27% |
| Dec 31, 2021 | 397.81M | 64.72M | 19.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.72B |
| Guangdong Biolight Meditech | 1.12B |
| Guangdong Transtek Medical Electronics | 1.05B |
| Jiangsu Hanbon Science and Technology | 849.02M |
| Beijing Leadman Biochemistry | 485.94M |
| Tellgen | 393.84M |
| Shanghai General Healthy Information and Technology | 350.19M |
| CareRay Digital Medical Technology | 322.80M |